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Summary
Objectives: To investigate the effects of exercise and osteochondral (OC) injury on type II collagen degradation products (collagenase cleav-
age neoepitope commercially known as C2C) in synovial ﬂuid (SF) from Thoroughbred (TB) racehorses and to compare these results with
radiographic and arthroscopic scores of severity of joint injury.
Methods: Metacarpophalangeal/metatarsophalangeal (MCP/MTP) and carpal SF was obtained from (1) 20 normal rested horses, (2) the same
horses after 5 to 6 months of race training, and (3) 27 horses with OC injury from racing. For group 3, radiographic and arthroscopic scores
were determined. Concentrations of SF C2C were determined by ELISA.
Results: SF C2C concentrations in OC injured carpal and MCP/MTP joints were signiﬁcantly different than rested and exercised joints
(P< 0.01). However, carpal and MCP/MTP SF C2C concentrations were not signiﬁcantly different between rested and exercised groups. Ar-
throscopic scores were signiﬁcantly higher for OC injured carpal than OC injured MCP/MTP joints (P¼ 0.002). OC injured SF C2C concen-
trations were positively correlated with radiographic and arthroscopic scores. Arthroscopic scores were positively correlated with radiographic
scores. SF C2C concentrations 64 pmol/mL for MCP/MTP joints and 75 pmol/mL for carpal joints discriminated OC injured joints from res-
ted or exercised joints.
Conclusion: OC injury caused a signiﬁcant increase in SF C2C concentrations in carpal and MCP/MTP joints compared to rested and exer-
cised horses. SF C2C concentrations were correlated to severity of joint injury. Based on these ﬁndings, SF C2C analysis may be useful for
evaluation of joint injury.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Collagen degradation, C2C, Horse, Synovial ﬂuid, Osteochondral injury, Exercise.Introduction
Type II collagen is a major component of articular cartilage.
Degradation of type II collagen is increased in osteoarthri-
tis (OA) and is mediated by matrix metalloproteinases
(MMP- 1, -8, -13, and -14) that cleave the collagen triple
helix into 3/4 and 1⁄4 length fragments
1. This cleavage ex-
poses a neoepitope (Col2-3/4Clong, currently known as
C2C) at the carboxy terminus of the 3/4 length type II col-
lagen cleavage product. Collagen degradation products
are released from the cartilage into the synovial ﬂuid
(SF)2. The amount of C2C products in SF increases with
joint inﬂammation in rabbits3 and anterior cruciate transec-
tion in dogs4. In a study that included human patients with
either inﬂammatory arthritis or OA, SF C2C concentrations
were reported to be elevated for both groups, although no
normal values were included for comparison5. Based on
these studies, SF C2C concentrations may serve as a use-
ful biomarker regarding joint health.aCurrent address: 1365 Gortner Avenue, College of Veterinary
Medicine, University of Minnesota, St. Paul, MN 55108, USA.
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371SF biomarkers have been investigated in horses to iden-
tify exercise and injury related changes in joints6e9. In an
equine study using surgically created osteochondral (OC)
injury combined with treadmill exercise, it was shown that
both exercise and injury increased SF 234CEQ (equine
speciﬁc collagenase cleavage neoepitope similar to C2C)
concentrations10. Currently, there are no studies on the ef-
fects of racetrack exercise and clinical OC injury on SF C2C
concentrations in horses. Most horses with OC injury
develop OA and therefore the horse serves as a model to
study injury and the subsequent development of OA.
The speciﬁc purposes of this study were (1) to investigate
the effects of racetrack exercise and clinical OC injury on
metacarpophalangeal/metatarsophalangeal (MCP/MTP)
and carpal SF C2C concentrations and (2) correlate these
concentrations with severity of joint injury, as determined
by radiographic and arthroscopic scores.Materials and methodsSTUDY ANIMALS AND EXPERIMENTAL DESIGNSF was obtained from 3 groups of Thoroughbred (TB) horses: (1) Rested
group: 20 horses (age range 14e20 months) purchased from July through
September 2004 for resale at 2-year-old in training sales (February through
April 2005) were included in the study. All horses were conﬁrmed normal by
clinical and radiographic examination by the attending veterinarian prior to
the study. SF samples were collected from MCP joints (n¼ 20) and middle
carpal (n¼ 14) or radiocarpal joints (n¼ 6) of these horses before the start
of race training. (2) Exercised group: Horses from group 1 were all subjected
372 T. N. Trumble et al.: Osteochondral injury increases SF C2Cto the same training program. Brieﬂy, all horses trotted to the racetrack, fast
galloped at speeds of 22 seconds per furlong (32 km/hr) for 1.5 miles, and
walked back to their stalls 6 days per week. After 2 months, horses were gal-
loped at speeds of 18 to 22 seconds per furlong (32 to 40 km/hr) 5 days per
week and additionally introduced to high speed exercise (breezing) 1 day per
week at speeds of 14 seconds per furlong (53 km/hr) for 1 to 2 furlongs,
followed by 1 day of rest. At the end of 5 to 6 months of training, just prior
to their 2-year-old in training sales, the same joints were sampled as in group
1. (3) OC injury group: SF was collected from racehorses (age range 2e7
years) undergoing MCP (n¼ 12), MTP (n¼ 1), middle carpal (n¼ 9), or ra-
diocarpal (n¼ 5) joint arthroscopy for removal of OC fragments, which
were injuries resulting from racing. These fragments were removed from
the dorsal articular borders of the third, radiocarpal, and intermediate carpal
bones, the distal radius, and the proximal phalanx. The study protocol was
approved by the University of Florida Institutional Animal Care and Use Com-
mittee. SF samples were aseptically collected by needle arthrocentesis,
centrifuged, decanted, and stored at 80 C until assayed.PROCEDURE FOR THE C2C IMMUNOASSAYCollagenase-mediated cleavage of type II collagen was measured in SF
using a commercially available competitive C2C (COL 2-3/4C long mono an-
tibody) ELISA (IBEX Technologies Inc., Montreal, CAN) that has been previ-
ously validated for use in horses11,12. SF samples were assayed with
appropriate dilutions, but without digestion.ARTHROSCOPIC AND RADIOGRAPHIC SCORESAvailable arthroscopic images, videos, and surgical reports of OC injured
horses were reviewed and scores were assigned using a scoring system de-
veloped by the authors9. Possible arthroscopic scores were 0e37. Similarly,
available radiographs for the OC injured horses were reviewed and scores
assigned as previously described9. Possible radiographic scores were 0e30.STATISTICAL ANALYSISFig. 1. Vertical scatter plot of SF C2C concentrations for MCP/MTP
joints (top) and carpal joints (bottom) in rested, exercised, and OC
injured TB racehorses. The short horizontal solid lines represent
the mean value for each group. The horizontal dashed lines repre-
sent SF concentrations (64 pmol/mL for MCP/MTP joints andData were assessed for normality by the Kolmogorov-Smirnov test. Differ-
ences between groups were determined by one-way analysis of variance
and a post hoc Tukey’s multiple-comparison test. P< 0.05 was considered
signiﬁcant. Sensitivity, speciﬁcity, positive predictive value, and negative pre-
dictive value of SF C2C concentration to discriminate between OC injured
and normal (rested and exercised values combined) joints were determined
by Fisher’s exact test. Correlations were assessed by the Spearman corre-
lation and dummy variables were used to represent the different joints af-
fected (MCP¼ 1, MTP¼ 2, MCJ¼ 3, RCJ¼ 4).75 pmol/mL for carpal joints) for which there is predictive value
in discriminating OC injured horses from rested or exercised
horses. Like letters represent no signiﬁcant difference.
Table I
Sensitivity, specificity, positive predictive value, and negative pre-
dictive value of SF C2C assay to discriminate between OC injured













85 89 73 94
Carpal
(75 pmol/mL)
85 92 79 95Results
In the normal horses in the study, mean concentrations
of C2C in MCP and carpal SF did not change signiﬁcantly
after 5 to 6 months exercise (Fig. 1). Concentrations of SF
C2C from OC injured MCP/MTP and carpal joints were
signiﬁcantly different than from rested and exercised
joints (P< 0.01; Fig. 1). Mean radiographic scores
( SD) for OC injured MCP/MTP joints (7.9 3.5;
n¼ 13) were not signiﬁcantly different than those for OC
injured carpal joints (11.2 4.9; n¼ 13; P¼ 0.06). How-
ever, mean arthroscopic scores ( SD) for OC injured
MCP/MTP joints (13.3 2.1; n¼ 9) were signiﬁcantly
lower than those for OC injured carpal joints (19.6 3.8;
n¼ 9; P¼ 0.002).
SF C2C concentrations 64 pmol/mL for MCP/MTP joints
and 75 pmol/mL for carpal joints were arbitrarily chosen to
determine predictive value for discriminating OC injured
horses from restedor exercised horses. This yieldedapositive
predictive valueof 73%andanegative predictive value of 94%
for the MCP/MTP joints, and positive predictive value of 79%
and negative predictive value of 95% for the carpus (Table I).
Overall, OC injured SF C2C concentrations were posi-
tively correlated with radiographic scores (R¼ 0.43;
P¼ 0.03) and arthroscopic scores (R¼ 0.52; P¼ 0.03). Ar-
throscopic scores were positively correlated with radio-
graphic scores (R¼ 0.51; P¼ 0.04). Arthroscopic scoresalso correlated with the joint affected, with higher scores as-
sociated with the carpus (R¼ 0.59; P¼ 0.009).Discussion
Concentrations of C2C in MCP/MTP and carpal SF did
not increase signiﬁcantly after exercise. This is in contrast
to a previous report on 2-yr-old treadmill exercised horses
with or without surgically created OC injury10. Those horses
traveled similar distances and speeds to our exercised
group. Other than being trained on a treadmill rather than
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for only 91 days with a 2-week rest period after 21 days. In-
terestingly, their SF 234CEQ values started to increase dur-
ing the 2-week rest period. The difference in the type of
exercise provided by a treadmill compared to a racetrack
may have contributed to the difference in results.
The C2C immunoassay discriminates between normal
(rested and exercised) and OC injured MCP/MTP and car-
pal joints (Fig. 1). Higher SF C2C concentrations in OC in-
jured joints would suggest increased MMP-mediated
cleavage of collagen in the cartilage matrix of these joints.
In a study that reported elevated SF C2C concentrations
in human patients with either inﬂammatory arthritis or OA,
SF C2C concentrations correlated with several measures
of local and systemic disease. These included C-reactive
protein, plasma viscosity, arthroscopic synovitis scores,
Health Assessment Questionnaire, and SF tumor necrosis
factor-a (TNF-a) and MMP-1 concentrations5. Similarly,
we also documented positive correlation between SF C2C
concentrations and severity of injury, as indicated by radio-
graphic and arthroscopic scores for OC injured joints. This
is similar to our previous study on OC injured horses in
which we showed that serum bone alkaline phosphatase
(BAP) concentrations correlated with radiographic and ar-
throscopic scores and SF: serum BAP correlated with ar-
throscopic scores9. In order to be of practical relevance
and to have diagnostic potential, it is essential that bio-
markers of joint disease are reﬂective of clinical and imag-
ing evidence of severity of the disease.
We observed that carpal joints had higher arthroscopic
scores when compared to the MCP/MTP joints. Although car-
pal radiographic scores were not signiﬁcantly higher than
those for the MCP/MTP joints (P¼ 0.06), the difference may
have clinical signiﬁcance when considered in conjunction
with the arthroscopic scores. It appears that OC injuries in
the carpus tend to result in greater overall joint damage
than in the MCP/MTP joint. These differences in injury scores
may be a result of inherent differences in the biomechanical or
biochemical properties between different joints9,14e17.
Our previous study showed signiﬁcant differences in SF
BAP concentrations between the MCP/MTP joints and car-
pal joints, in both normal and OC injured horses9. Although
our current study did not show signiﬁcant differences in SF
C2C concentrations between these joints, we found that we
had to use different cut-off values for SF C2C (64 pmol/
mL for MCP/MTP joints and 75 pmol/mL for carpal joints)
to calculate predictive values. This further suggests that for
diagnostic purposes, normal biomarker values must be es-
tablished for each joint of interest.
The ability of the assay to distinguish the effects of OC in-
jury on SF C2C concentration could lead to diagnostic appli-
cations. Negative predictive value is clinically relevant
because it helps determine the probability that a joint clas-
siﬁed as negative by the assay is indeed normal (non-in-
jured). In contrast, positive predictive value helps
determine the probability that a joint classiﬁed as positive
by the assay is indeed injured. The assay performed well
in both regards, with a greater accuracy of predicting normal
(94e95%) than injured joints (73e79%). In contrast to our
results, in a study on horses diagnosed with MCP or MTP
joint lameness, there were no signiﬁcant differences in SF
C2C concentrations between horses which showed a posi-
tive response to intra-articular anesthesia and those that did
not18. Similarly, SF C2C concentrations were similar be-
tween horses that had osteochondritis dessicans of the dis-
tal intermediate ridge of the tibia and those with normal
joints19.This study had limitations. Complete medical records, in-
cluding arthroscopic and radiographic images, were not
available for some of the horses with OC injury. This pre-
cluded assignment of arthroscopic (n¼ 9) and radiographic
(n¼ 1) scores for these individuals. Previous therapy and
the duration of the OC injury before sampling were gener-
ally unknown, which is often a limitation of clinical case ma-
terial. Racehorses with musculoskeletal injury are
commonly treated with phenylbutazone, a non-steroidal
anti-inﬂammatory drug. However, a recent study has shown
that phenylbutazone therapy for 7 days does not signiﬁ-
cantly effect serum or SF C2C concentration in resting
horses20. In our study, the ages of the normal (rested and
exercised) and OC injured groups were different. Intuitively,
it would seem that the younger horses would be more met-
abolically active and therefore might have higher SF C2C
values. However, these younger, normal horses had lower
values than the OC injured group. Therefore it is difﬁcult
to comment on the effect of age in our study. In another
study, serum, rather than SF 234CEQ, was evaluated in
foals during the ﬁrst 11 months of life; neither exercise nor
age had any effect13.
We evaluated C2C concentrations only in SF in our
study. Comparison of these values with those in other
body ﬂuids, such as serum and urine may have been useful.
Because of the difﬁculty on obtaining SF from human pa-
tients, serum and urine are often relied upon for human
studies. However, SF should be examined when possible
in joint disease biomarker studies, because it is a part of
the organ under investigation. In this regard, horses are
a good model for the study of joint injury and OA in hu-
mans21, because high volumes (usually 2 mL) can be
consistently collected without lavage.
In conclusion, we have shown that OC injury causes a sig-
niﬁcant increase in SF C2C content in the MCP/MTP and
carpal joints of horses and that these increases are corre-
lated to severity of joint injury. Furthermore, joint injury
scores (based on arthroscopic and radiographic ﬁndings)
tend to be higher in the carpus compared to the MCP/
MTP joint. Selection of arbitrary SF C2C concentrations
for each joint yielded high negative and positive predictive
values for the discrimination of normal and OC injured
joints. This provides rationale for using different SF C2C
concentrations to establish criteria for using this biomarker
as a diagnostic tool for different joints. Based on these ﬁnd-
ings, SF C2C analysis may prove a useful tool for evalua-
tion of joint injury.Conﬂict of interest
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